A Phase 1 Randomized Double-Blind Placebo-Crossover Safety Trial of DAS181 (Fludase) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis.

Trial Profile

A Phase 1 Randomized Double-Blind Placebo-Crossover Safety Trial of DAS181 (Fludase) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs DAS 181 (Primary)
  • Indications Influenza A virus H1N1 subtype; Influenza A virus H5N1 subtype; Influenza virus infections; Parainfluenza virus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 29 Jul 2010 Planned end date changed from 1 May 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov (NCT01113034).
    • 29 Jul 2010 Planned end date changed from 1 May 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov (NCT01113034).
    • 29 Jul 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov (NCT01113034).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top